Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 5/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760242 | 0.98 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL4038797 | 0.97 | ALDH1A1 (0.53) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL4041048 | 0.92 | ALDH1A1 (0.49) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL12582344 | 0.82 | LMNA (0.47) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL30282427 | 0.82 | LMNA (0.47) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL25136383 | 0.82 | LMNA (0.47) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL1759846 | 0.82 | LMNA (0.66) | ALDH1A1KDM4ELMNATDP1CYP1A2 | |
| SCHEMBL13556488 | 0.82 | ALDH1A1 (0.42) | ALDH1A1KDM4ELMNANQO2P2RX3 | |
| SCHEMBL7236755 | 0.81 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 | |
| SCHEMBL30667782 | 0.81 | ALDH1A1 (0.55) | ALDH1A1KDM4ELMNATDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1268443-B1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SMITHKLINE BEECHAM PLC (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20030114674-A1 | 2-Hydroxy-mutilin carbamate derivatives for antibacterial use | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-06-19 | — | — | US | disclosed |
| EP-1268443-A1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SmithKline Beecham p.l.c. (GB) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074788-A1 | 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE | SMITHKLINE BEECHAM PLC (GB) | 2001-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114674-A1 | 2-Hydroxy-mutilin carbamate derivatives for antibacterial use | MSH6, MSH2, PMS2 | ALDH1A1 1967/4885KDM4E 1084/4885LMNA 4396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.